Aptose Doses First CLL Patient in Phase 1 Study of CG-806 and Doses Third Cohort in Phase 1 Study of APTO-253 Jul 16, 2019 7:05am EDT
Aptose Presents New Preclinical Data for CG-806 at the 24th Congress of the European Hematology Association Jun 14, 2019 7:00am EDT
Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders Jun 04, 2019 4:02pm EDT
Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association May 16, 2019 10:02am EDT
